THE USE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR STAGING CLINICALLY LOCALIZED PROSTATE CANCER
- 1 April 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 159 (4) , 1238-1242
- https://doi.org/10.1016/s0022-5347(01)63571-7
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisUrology, 1997
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- The Free-to-Total Serum Prostate Specific Antigen Ratio for Staging Prostate CarcinomaJournal of Urology, 1997
- Free-to-Total Prostate Specific Antigen Ratio as a Single Test for Detection of Significant Stage T1c Prostate CancerJournal of Urology, 1996
- A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenarioJournal of Urology, 1996
- Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screeningPublished by American Medical Association (AMA) ,1995
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- Alpha1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatc hyperplasiaUrology, 1994
- The TNM classification of prostate cancerThe Prostate, 1992
- Prostate-Specific Antigen: Its Role in Early Detection, Staging, and Monitoring of Prostatic CarcinomaJournal of Endourology, 1989